CNS Pharmaceuticals, Inc.
CNSP
$6.12
-$0.42-6.42%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 12.13M | 13.05M | 6.46M | 6.97M | 1.49M |
| Total Receivables | -- | -- | 882.50K | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.99M | 653.80K | 1.29M | 388.00K | 637.10K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 14.20K | 20.60K | 20.60K | 26.90K | 16.80K |
| Total Current Assets | 14.14M | 13.72M | 8.66M | 7.39M | 2.15M |
|
|
|||||
| Total Current Assets | 14.14M | 13.72M | 8.66M | 7.39M | 2.15M |
| Net Property, Plant & Equipment | 3.80K | 4.90K | 6.00K | 2.80K | 3.60K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 366.30K | 22.40K | 36.40K | 18.40K | 320.30K |
| Total Assets | 14.51M | 13.75M | 8.70M | 7.41M | 2.47M |
|
|
|||||
| Total Accounts Payable | 1.26M | 2.57M | 2.20M | 4.03M | 6.64M |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | 121.80K | 210.70K | 326.10K | 31.20K | 123.20K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 1.38M | 2.78M | 2.52M | 4.06M | 6.76M |
|
|
|||||
| Total Current Liabilities | 1.38M | 2.78M | 2.52M | 4.06M | 6.76M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 121.80K | 210.70K | 326.10K | 31.20K | 123.20K |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 1.38M | 2.78M | 2.52M | 4.06M | 6.76M |
|
|
|||||
| Common Stock & APIC | 104.23M | 99.70M | 90.60M | 84.60M | 71.35M |
| Retained Earnings | -91.10M | -88.73M | -84.42M | -81.25M | -75.64M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 13.13M | 10.97M | 6.18M | 3.35M | -4.29M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 13.13M | 10.97M | 6.18M | 3.35M | -4.29M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 13.13M | 10.97M | 6.18M | 3.35M | -4.29M |
|
|
|||||